Choose your sales office

News

ELITechGroup

Filter

Open filter menu
Reset
Reset

ELITechGroup Launches Second IVDR Certified Gastrointestinal Infection Assay: GI Parasitic PLUS ELITe MGB® Kit 

ELITechGroup launches their second kit of the Gastrointestinal infection assay panel targeting parasitic pathogens.  The ELITe MGB Gastrointestinal assays are IVDR-certified in combination with InGenius and BeGenius, fully automated samples-to-results instruments.  The company will shortly launch two more gastrointestinal assay infection panels targeting viral pathogens and Norovirus.   ELITechGroup announces the…
READ MORE

ELITechGroup launches CE-IVDR certified GI Bacterial PLUS ELITe MGB® Kit and expands in vitro diagnostic portfolio

ELITechGroup launches their first kit of the Gastrointestinal assay panel targeting bacterial pathogens. ELITechGroup is planning to launch three additional kits covering the full range of gastrointestinal infections within the next quarter. In a significant move towards advancing global diagnostic capabilities, ELITechGroup proudly announces the introduction of the GI Bacterial…
READ MORE

ELITechGroup obtains new IVDR certificate for PCR assays

After the release of the first IVDR certificate at the beginning of the year ELITech Group continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories. The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR compliant by 2026…
READ MORE

ELIVERSE: the video teaser

https://www.elitechgroup.com/news/wp-content/uploads/sites/33/2023/04/Eliver-Teaser-1.1-1-1.mp4   ElitechGroup Mdx is pleased to announce that ELIVERSE will be launched in Europe in 2024. With its introduction, ELITechGroup will have launched three molecular sample-to-result platforms in 8 years. Read the press release here.
READ MORE

Our new Molecular MDR/MTB multiplex assay

Een high performance based on our MGB® technology: – MTB complex: M.tuberculosis, M.africanum, M.bovis, M.canetti, M.microti, M.caprae. – MGB resistence: Rifampicine en Izoniazide. – Ultra sensitive: 6CFU/ml! – Ready to use monoreagent. In combination with our RT-PCR Sample-to-Result ELITe InGenius the most flexible solution for the diagnosis of Tuberculosis. “
READ MORE

ELITechGroup announces the launch of ELITe BeGenius®

ITALY, Torino, October 12th, 2021. It is with great satisfaction that ELITechGroup announces the launch of ELITe BeGenius®, the new CE-IVD stand-alone “Sample – to – Result” Real Time PCR solution. ELITe BeGenius® makes molecular biology universally accessible thanks to its compact footprint, exceptional ease-of-use, and total automation. Tailorable for…
READ MORE

ELITECHGROUP ACQUIRES GONOTEC, A LEADING MARKET PLAYER IN FREEZING POINT OSMOMETRY

  ELITechGroup, market leader in global vapor pressure osmometer technology, announces the acquisition of GONOTEC, a leading market player in freezing point osmometer technology. The purchase of the company unites two osmometry market leaders, providing the industry with a full range of osmometry solutions that meet specific needs enabling physicians…
READ MORE

Coronavirus (COVID 19): New CE-IVD Kit now available worldwide

ITALY, Torino, Mar, 03, 2020. ELITechGroup is pleased to announce the release of the GeneFinderTM COVID-19 Plus RealAmp Kit by OSANGHealthcare. The Kit is CE-IVD certified and detects SARS-CoV-2 on all major PCR cyclers as well as on the Sample-to Result-Platform ELITe InGenius® The test will complement the menu of…
READ MORE

New innovative molecular multiplex STI Plus assay

De ELITe MGB® STI PLUS Kit is the firtst CE-IVD multiplex RT-PCR test which is validated on a Sample-To-Result instrument; the ELITe InGenius® . In 1 single reaction 4 targets are detected: C. trachomatis, N. gonorrhoeae, M. genitalium, en T. vaginalis. De STI PLUS quadroplex test validated on the matrices…
READ MORE

Cystic Fibrosis Can Lead to Other Conditions

Macroduct Advanced and Baby
If you suffer from Cystic Fibrosis, then you already know the struggles associated with having the disease, but can CF lead to more? Recent studies have shown that it might. In a study published in the Cystic Fibrosis Journal, researchers were eager to determine the effects of Cystic Fibrosis and…
READ MORE